溶解性 | Soluble in DMSO and dilute alkali hydroxides. Insoluble in water |
密度 | 1.4500 |
生化机理 | Flumequine inhibits topoisomerases, which are needed for the transcription and replication of bacterial DNA. The inhibition of the topoisomerases results in strand breakage of the bacterial chromosome, supercoiling, and resealing. Therefore, DNA replication and transcription is inhibited . |
别名 | 氟甲喹;9-氟-1,5,6,7-四氢-5-甲基-1-氧代吡啶并[3,2,1-ij]喹啉-2-羧酸;9-氟-6,7-二氢-5-甲基-1-氧代-1H,5H-苯并(ij)喹嗪-2-羧酸;;9-Fluoro-6,7-dihydro-5-methyl-1-oxo-1H,5H-benzo[ij]quinolizine-2-carboxylic acid;9-Fluoro-1,5,6,7-tetrahydro-5-methyl-1-oxopyrido[3,2,1-ij]quinoline-2-carboxylic Acid |
氟甲喹
Flumequine (订货以英文为准)
编号:F131683
CAS号:42835-25-6
分子式:C14H12FNO3
分子量:261.25
产品名称 | Flumequine |
中文名称 | 氟甲喹 |
CAS号 | 42835-25-6 |
分子式(M.F.) | C14H12FNO3 |
分子量(M.W.) | 261.25 |
标识符号 | https://www.aladdin-e.com/images/ghs/ghs07.jpg,https://www.aladdin-e.com/images/ghs/ghs08.jpg |
信号词 | Danger |
危害声明 | H302,H312,H332,H360 |
警示性声明 | P201,P280,P308+P313 |
个人防护设备 | Eyeshields,full-face particle respirator type N100 (US),Gloves,respirator cartridge type N100 (US),type P1 (EN143) respirator filter,type P3 (EN 143) respirator cartridges |
RTECS | EX8930000 |
WGK德国 | 3 |
风险声明 (欧洲) | 61,20/21/22 |
安全声明(欧洲) | 53,22,36/37/39,45 |
危害码(欧洲) | T |
搜索质检报告(COA)
搜索MSDS
相关产品